Detalhe da pesquisa
1.
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma.
Clin Cancer Res
; 30(8): 1619-1629, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295144
2.
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.
Clin Cancer Res
; 30(2): 379-388, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939133
3.
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Nat Cancer
; 2(12): 1372-1386, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121903
4.
Ribosomal protein S11 influences glioma response to TOP2 poisons.
Oncogene
; 39(27): 5068-5081, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32528131
5.
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Nat Cancer
; 3(3): 373, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149861